This is a hypothetical case study provided as an example. It should not be cited as evidence in an application. Although the data and discussions are representative, this example may not include all considerations needed when assessing risks from a proposed GM plant limited and controlled release.
Commercial release of canola genetically modified for herbicide tolerance and a hybrid breeding system (MS11× RF3 and MS11 × RF3 × MON 88302)
Limited and controlled release of canola genetically modified for increased abiotic stress tolerance.
Misinformation has been circulating regarding mRNA COVID-19 vaccines and gene therapy. The following statement addresses this misinformation.
Commercial release of cotton genetically modified for herbicide tolerance (MON 88701)
Clinical trial for the treatment of mycobacterial infections using bacteriophages
This Communique covers matters considered at the 38th videoconference of the Gene Technology Technical Advisory Committee (17 June 2024).
Details of OGTR monitoring and compliance activities during the quarter ended 30 June 2024.
This Communique covers matters considered at the 20th meeting of the Gene Technology Ethics and Community Consultative Committee (10 May 2024).
This document provides a step by step guide on how to access the form to suspend a certification in the OGTR's Online Services Portal.